Loading...
Phibro Animal Health Corporation
PAHC•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$28.92
$-0.26(-0.89%)
Phibro Animal Health Corporation (PAHC) AI-Powered Stock Analysis
See how Phibro Animal Health Corporation scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerPhibro Animal Health Corporation (PAHC) Stock Overall Grade
Phibro Animal Health Corporation’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
B
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to Phibro Animal Health Corporation's overall stock rating.
Forecast
AScore
81/100Financial Growth
B+Score
70/100Fundamental Growth
BScore
62/100Key Ratios
C+Score
57/100Sector Comparison
B+Score
75/100Industry Comparison
B+Score
75/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
C+Score
50/100Phibro Animal Health Corporation (PAHC) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 81/100 (A), reflecting high confidence in its potential. Financial Growth (70/100, B+) and Fundamental Growth (62/100, B) highlight its stability, while Key Ratios (57/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (85/100, A), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Phibro Animal Health Corporation stock grade, including financials, comparisons, and forecasts.